cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.tbgqmk
title: Occurrence Download

description: A dataset containing 42182 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Trichogramma ostriniae Pang & Chen, 1974, Hemiptarsenus waterhousii Westwood, 1833, Copidosoma koehleri Blanchard, 1940, Tamarixia triozae (Burks, 1943), Euplectrus flavipes (Fonscolombe, 1832), Dinarmus colemani (Crawford, 1913), Pteromalus hunteri (Crawford, 1908), Gahaniella californica Timberlake, 1926, Eulophus pennicornis Nees, 1834, Anagrus atomus (Linnaeus, 1767), Eretmocerus mundus Mercet, 1931, Diglyphus intermedius (Girault, 1916), Peronospora tabacina D.B.Adam, Phytophthora nicotianae Breda de Haan, Aculops lycopersici (Tryon, 1917), Conepatus semistriatus amazonicus (Lichtenstein, 1838), Rhectocraspeda periusalis (Walker, 1859), Erysiphe palczewskii (Jacz.) U.Braun & S.Takam., Grapholita orobana (Treitschke, 1830), Acronicta tridens (Denis & Schiffermüller), 1775, Tautoprosopa transcaspia Emeljanov, 1978, Tetracnemus heydeni (Mayr, 1876), Monodiscodes intermedius (Mayr, 1876), Tetracnemus simillimus (Hoffer, 1953), Systasis parvula Thomson, 1876, Eurytoma caraganae Nikol'skaya, 1952, Woronichina tranzschelii (Woron.) Naumov, Neolycaena rhymnus (Eversmann, 1832), Setapius apiculatus (Fieber, 1876), Systasis halimodendronis Dzhanokmen, 1996, Gastrancistrus sugonjaevi Dzhanokmen, 1995, Pseudocatolaccus arcuatus Dzhanokmen, 1979, Torymus spilopterus Boheman, 1834, Trechnites flavipes (Mercet, 1921), Hyaloperonospora dentariae (Rabenh.) Voglmayr, Ramularia cardamines Syd. & P.Syd., Ceutorhynchus cochleariae Schoenherr, 1837, Ceutorhynchus typhae (J.F.W.Herbst, 1795), Palomena viridissima (Poda, 1761), Scolopostethus affinis (Schilling, 1829), Ceutorhynchus pervicax Weise, 1883, Bruchus loti Paykull, 1800, Chrysoprasis aurigena (Germar, 1824), Xyleus discoideus angulatus (Stål, 1873), Leptocoris tagalicus Burmeister, 1834, Cyclargus thomasi (Clench, 1941), Charaxes varanes Cramer, 1764, Nica flavilla Godart, 1823, Thecla bebrycia Hewitson, 1868, Diaethria astala (Guérin-Méneville, 1844))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 42182 records from 632 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0015282-250515123054153/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.15494649
title: From Algorithms to Amenities: Mapping the Path from AI Adoption to Guest Experience and Satisfaction in Hospitality

description: This study maps how hotel-level artificial intelligence (AI) adoption diffuses through three guest-facing technologies—chatbots, augmented-reality (AR) applications, and virtual influencers (VIs)—to shape guest experience and, ultimately, post-stay satisfaction. Guided by the stimulus–organism–response framework, AI adoption is modelled as the stimulus, the three AI touchpoints as organisms, and guest experience and satisfaction as sequential responses. Data were collected from 300 Generation Y/Z travellers who had interacted with at least one AI touchpoint during a recent hotel stay. The model was tested with partial least-squares structural-equation modelling (SmartPLS 4), using a two-step measurement-and-structural approach and bias-corrected bootstrapping. AI adoption strongly enhances the perceived quality of chatbots, AR and VIs. AR exerts the largest positive effect on guest experience and produces the strongest serial indirect impact on satisfaction. VI effectiveness also improves experience and, via experience, satisfaction. In contrast, chatbot quality shows a small negative effect on experience and no significant indirect path to satisfaction, revealing an empathy gap despite technical competence. Guest experience remains the pivotal conduit to satisfaction. Hotels should prioritise immersive AR rollouts, use VIs as narrative enhancers, and redesign chatbots with empathetic scripts and human hand-offs to recover experiential warmth. This research provides the first multi-touchpoint serial-mediation test linking AI capability to experiential and evaluative outcomes in hospitality and empirically documents conditions under which conversational AI can harm rather than help the guest journey.
DOI: 10.5281/zenodo.15494650
title: From Algorithms to Amenities: Mapping the Path from AI Adoption to Guest Experience and Satisfaction in Hospitality

description: This study maps how hotel-level artificial intelligence (AI) adoption diffuses through three guest-facing technologies—chatbots, augmented-reality (AR) applications, and virtual influencers (VIs)—to shape guest experience and, ultimately, post-stay satisfaction. Guided by the stimulus–organism–response framework, AI adoption is modelled as the stimulus, the three AI touchpoints as organisms, and guest experience and satisfaction as sequential responses. Data were collected from 300 Generation Y/Z travellers who had interacted with at least one AI touchpoint during a recent hotel stay. The model was tested with partial least-squares structural-equation modelling (SmartPLS 4), using a two-step measurement-and-structural approach and bias-corrected bootstrapping. AI adoption strongly enhances the perceived quality of chatbots, AR and VIs. AR exerts the largest positive effect on guest experience and produces the strongest serial indirect impact on satisfaction. VI effectiveness also improves experience and, via experience, satisfaction. In contrast, chatbot quality shows a small negative effect on experience and no significant indirect path to satisfaction, revealing an empathy gap despite technical competence. Guest experience remains the pivotal conduit to satisfaction. Hotels should prioritise immersive AR rollouts, use VIs as narrative enhancers, and redesign chatbots with empathetic scripts and human hand-offs to recover experiential warmth. This research provides the first multi-touchpoint serial-mediation test linking AI capability to experiential and evaluative outcomes in hospitality and empirically documents conditions under which conversational AI can harm rather than help the guest journey.
DOI: 10.6084/m9.figshare.29135099
title: Supplementary Material for: Implementation of a multidisciplinary medical-surgical consultation in hidradenitis suppurativa improves patient journey and time to surgery

description: Introduction
Surgery is a crucial part in the treatment of hidradenitis suppurativa (HS). The integration of surgical and medical treatment is sometimes difficult to achieve as it involves different specialists. The aim of this study is to describe and evaluate the role of a multidisciplinary medical-surgical consultation for patients with HS.

Methods
We performed a cohort study to describe patient characteristics, assess referral reasons, analyse decisions made during the multidisciplinary consultation and evaluate its impact on time to surgery and disease control.

Results
The profile of the patient referred to the multidisciplinary consultation is a man with severe disease. The lesions prompting referral were usually located on the lower part of the body. Surgery was indicated in 73.91% of patients. In terms of medical treatment, 30.43% of patients underwent modifications to their biological therapy, including the introduction of a new biologic drug and target (23.91%) or dosage changes (6.52%). There was a significant reduction in the waiting time to be operated by general surgery after the implementation of this consultation (420.65 vs 167 days).

Conclusions
The results of this study suggest that the presence of a multidisciplinary surgical consultation in HS may be useful in treating patients with complex structural disease, optimising resources and improving comprehensive patient care. Additionally, it can have a positive impact on time to surgery, which is highly relevant for a progressive disease such as HS.
DOI: 10.6084/m9.figshare.29135099.v1
title: Supplementary Material for: Implementation of a multidisciplinary medical-surgical consultation in hidradenitis suppurativa improves patient journey and time to surgery

description: Introduction
Surgery is a crucial part in the treatment of hidradenitis suppurativa (HS). The integration of surgical and medical treatment is sometimes difficult to achieve as it involves different specialists. The aim of this study is to describe and evaluate the role of a multidisciplinary medical-surgical consultation for patients with HS.

Methods
We performed a cohort study to describe patient characteristics, assess referral reasons, analyse decisions made during the multidisciplinary consultation and evaluate its impact on time to surgery and disease control.

Results
The profile of the patient referred to the multidisciplinary consultation is a man with severe disease. The lesions prompting referral were usually located on the lower part of the body. Surgery was indicated in 73.91% of patients. In terms of medical treatment, 30.43% of patients underwent modifications to their biological therapy, including the introduction of a new biologic drug and target (23.91%) or dosage changes (6.52%). There was a significant reduction in the waiting time to be operated by general surgery after the implementation of this consultation (420.65 vs 167 days).

Conclusions
The results of this study suggest that the presence of a multidisciplinary surgical consultation in HS may be useful in treating patients with complex structural disease, optimising resources and improving comprehensive patient care. Additionally, it can have a positive impact on time to surgery, which is highly relevant for a progressive disease such as HS.
DOI: 10.6084/m9.figshare.29135102
title: Supplementary Material for: Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes

description: Introduction
In recent years, the therapeutic scenario of metastatic biliary tract cancers (BTC) beyond first-line has profoundly changed owing to target therapies. HER2 represents a promising molecular target that is frequently altered in BTC. The present meta-analyses are aimed to describe the response rates and survival outcomes in patients with HER2-positive locally advanced/metastatic BTC treated with anti-HER2 therapies. Moreover, the study is intended to provide an update on the evolving therapeutic scenario of HER2 overexpressed BTC.

Methods
We performed a systematic review of the literature to identify clinical trials investigating any regimen comprising a HER2 targeted therapy for metastatic BTC, and we conducted three subsequent meta-analyses on second-line phase II trials. The first one was performed to compare the group of HER2 3+ versus the group of HER2 2+ BTC patients for objective response rate (ORR). The second one compared patients according to the tumor location (gallbladder carcinoma [GBC] or extrahepatic cholangiocarcinoma [eCCA] versus intrahepatic cholangiocarcinoma [iCCA]) for ORR. The third one evaluated the overall outcomes in terms of overall survival (OS) and progression-free survival (PFS). 

Results
Patients with advanced BTC and HER2 3+ had better ORR compared to HER2 2+, with a 3.7-fold higher probability of experiencing objective responses (HR 3.70, 95% CI 1.34-10.25, p=0.0119). Likewise, patients with GBC or eCCA had a 2.74-fold higher probability of experiencing an objective response compared to patients with iCCA (HR 2.74, 95% CI 1.12-6.73, p=0.0275). The weighted pooled analysis of trials with anti-HER2 agents in second-line or beyond revealed a mPFS of 4.9 months (95% CI 4.2-5.6), while mOS was 10.8 months (95% CI 9.0-12.8).

Conclusions
Our meta-analyses have revealed improved efficacy in patients with HER2 3+ metastatic BTC and in patients with GBC or eCCA treated with anti-HER2 therapies, with a considerable mPFS and mOS in the overall population of the phase II trials analyzed. Further studies are paramount to confirm our preliminary results.
DOI: 10.6084/m9.figshare.29135102.v1
title: Supplementary Material for: Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes

description: Introduction
In recent years, the therapeutic scenario of metastatic biliary tract cancers (BTC) beyond first-line has profoundly changed owing to target therapies. HER2 represents a promising molecular target that is frequently altered in BTC. The present meta-analyses are aimed to describe the response rates and survival outcomes in patients with HER2-positive locally advanced/metastatic BTC treated with anti-HER2 therapies. Moreover, the study is intended to provide an update on the evolving therapeutic scenario of HER2 overexpressed BTC.

Methods
We performed a systematic review of the literature to identify clinical trials investigating any regimen comprising a HER2 targeted therapy for metastatic BTC, and we conducted three subsequent meta-analyses on second-line phase II trials. The first one was performed to compare the group of HER2 3+ versus the group of HER2 2+ BTC patients for objective response rate (ORR). The second one compared patients according to the tumor location (gallbladder carcinoma [GBC] or extrahepatic cholangiocarcinoma [eCCA] versus intrahepatic cholangiocarcinoma [iCCA]) for ORR. The third one evaluated the overall outcomes in terms of overall survival (OS) and progression-free survival (PFS). 

Results
Patients with advanced BTC and HER2 3+ had better ORR compared to HER2 2+, with a 3.7-fold higher probability of experiencing objective responses (HR 3.70, 95% CI 1.34-10.25, p=0.0119). Likewise, patients with GBC or eCCA had a 2.74-fold higher probability of experiencing an objective response compared to patients with iCCA (HR 2.74, 95% CI 1.12-6.73, p=0.0275). The weighted pooled analysis of trials with anti-HER2 agents in second-line or beyond revealed a mPFS of 4.9 months (95% CI 4.2-5.6), while mOS was 10.8 months (95% CI 9.0-12.8).

Conclusions
Our meta-analyses have revealed improved efficacy in patients with HER2 3+ metastatic BTC and in patients with GBC or eCCA treated with anti-HER2 therapies, with a considerable mPFS and mOS in the overall population of the phase II trials analyzed. Further studies are paramount to confirm our preliminary results.
DOI: 10.6084/m9.figshare.29135105
title: Supplementary Material for: Interprofessional collaboration and job satisfaction in German intensive care units - a cross-sectional survey within the PRiVENT project

description: Background: The multicentre cluster-randomized PRiVENT study aims to improve weaning of long-term ventilated patients in German intensive care units via a complex interprofessional intervention. To assess perceptions on interprofessional collaboration and job satisfaction among different health professions, a survey was conducted in four clusters, each comprising one weaning centre and 7-12 cooperation hospitals.
Methods: Three validated questionnaires were used to measure a) interprofessional socialization (7-level Likert scale), b) interprofessional collaboration (5-level) and c) job satisfaction (7-level). Alongside a descriptive analysis, a subgroup analysis was performed comparing mean scores between physicians and non-physicians and the four clusters. Correlation coefficients were calculated to check for correlations of age group and work experience with interprofessional collaboration and job satisfaction. 
Results: 62 questionnaires were returned by health workers of the intensive care units, corresponding to a response rate of 47%. Respondents rated interprofessional socialization (5.7 ± 0.6 ) and collaboration (3.8 ± 0.6) as good. Job satisfaction was high (5.1 ± 1.0), particularly regarding the collegial environment and variety of work tasks. Satisfaction with physical workload, income, and working hours was lower. Compared to physicians, overall ratings of non-physicians were lower, although the differences were not statistically significant, as were those between clusters. There was a statistically significant positive correlation of age group and work experience with overall job satisfaction. 
Conclusions: Health workers within PRiVENT are satisfied with their workplace conditions and rate interprofessional collaboration as good. Follow-up surveys will provide insights into the impact of PRiVENT on interprofessional cooperation and job satisfaction.
DOI: 10.6084/m9.figshare.29135105.v1
title: Supplementary Material for: Interprofessional collaboration and job satisfaction in German intensive care units - a cross-sectional survey within the PRiVENT project

description: Background: The multicentre cluster-randomized PRiVENT study aims to improve weaning of long-term ventilated patients in German intensive care units via a complex interprofessional intervention. To assess perceptions on interprofessional collaboration and job satisfaction among different health professions, a survey was conducted in four clusters, each comprising one weaning centre and 7-12 cooperation hospitals.
Methods: Three validated questionnaires were used to measure a) interprofessional socialization (7-level Likert scale), b) interprofessional collaboration (5-level) and c) job satisfaction (7-level). Alongside a descriptive analysis, a subgroup analysis was performed comparing mean scores between physicians and non-physicians and the four clusters. Correlation coefficients were calculated to check for correlations of age group and work experience with interprofessional collaboration and job satisfaction. 
Results: 62 questionnaires were returned by health workers of the intensive care units, corresponding to a response rate of 47%. Respondents rated interprofessional socialization (5.7 ± 0.6 ) and collaboration (3.8 ± 0.6) as good. Job satisfaction was high (5.1 ± 1.0), particularly regarding the collegial environment and variety of work tasks. Satisfaction with physical workload, income, and working hours was lower. Compared to physicians, overall ratings of non-physicians were lower, although the differences were not statistically significant, as were those between clusters. There was a statistically significant positive correlation of age group and work experience with overall job satisfaction. 
Conclusions: Health workers within PRiVENT are satisfied with their workplace conditions and rate interprofessional collaboration as good. Follow-up surveys will provide insights into the impact of PRiVENT on interprofessional cooperation and job satisfaction.
DOI: 10.6084/m9.figshare.29135108
title: Supplementary Material for: Eculizumab for Thrombotic Microangiopathy Induced by Onasemnogene Abeparvovec in Spinal Muscular Atrophy

description: Introduction
Onasemnogene abeparvovec is one of the three disease-modifying therapies available that can significantly improve the outcome of patients with 5q-spinal muscular atrophy. Therapy-induced thrombotic microangiopathy is an ultra-rare, but potentially life-threatening condition of not yet clearly defined aetiology.
Case Presentation
A case of a 2-year-old patient with 5q-spinal muscular atrophy, who developed thrombotic microangiopathy after gene replacement therapy with onasemnogene abeparvovec is described. This severe adverse event was promptly recognised and successfully treated with the complement C5 inhibitor. 
Conclusion
Thrombotic microangiopathy is an ultra-rare, but potentially life-threatening condition that can occur after onasemnogene abeparvovec therapy. Anticipation of these serious adverse event, its prompt recognition and treatment are crucial for a better outcome.
DOI: 10.6084/m9.figshare.29135108.v1
title: Supplementary Material for: Eculizumab for Thrombotic Microangiopathy Induced by Onasemnogene Abeparvovec in Spinal Muscular Atrophy

description: Introduction
Onasemnogene abeparvovec is one of the three disease-modifying therapies available that can significantly improve the outcome of patients with 5q-spinal muscular atrophy. Therapy-induced thrombotic microangiopathy is an ultra-rare, but potentially life-threatening condition of not yet clearly defined aetiology.
Case Presentation
A case of a 2-year-old patient with 5q-spinal muscular atrophy, who developed thrombotic microangiopathy after gene replacement therapy with onasemnogene abeparvovec is described. This severe adverse event was promptly recognised and successfully treated with the complement C5 inhibitor. 
Conclusion
Thrombotic microangiopathy is an ultra-rare, but potentially life-threatening condition that can occur after onasemnogene abeparvovec therapy. Anticipation of these serious adverse event, its prompt recognition and treatment are crucial for a better outcome.
DOI: 10.6084/m9.figshare.29135111
title: Supplementary Material for: Prognostic role of PD-L1 and IDO-1 expression in sinonasal carcinoma

description: Introduction: Sinonasal carcinomas (SNC) are rare, aggressive tumours with complex immunological aspects. Still, prognostic markers are missing. The study aimed to investigate the relationship between immune checkpoints - specifically programmed death-ligand 1 (PD-L1) and Indolamin-2,3-dioxygenase 1 (IDO-1) - and clinical parameters in SNC.
Methods: In this monocentric study immunohistochemical analysis of the checkpoints PD-L1 and IDO-1 was carried out in 85 SNC patients from 2004 to 2020. Tumour proportion score (TPS), combined positive score (CPS) and combined IDO-1 score classified the PD-L1 and IDO-1 expression. The study was conducted in a specialized tertiary care center, indicating comprehensive multidisciplinary care with surgical, radiotherapeutic and systemic treatment intervention.
Results: Over a median observation period of 41 months, 52 squamous cell carcinomas (SCC, 61%) and 33 adenocarcinomas (AC, 39%) were included. 31 patients (37%) were classified in UICC IV stage, 90.6 % (n=77) received a primary resection. 3-year progression-free survival (PFS)/-overall survival (OS) rates were 63.6% / 81.4% in SCC and 73.1% / 82.5% in AC, respectively. Sinonasal AC showed significantly more frequently negative PD-L1 expression and CPS &lt;1 compared to sinonasal SCC (p=0.035, p=0.002). Sinonasal SCC with TPS Score &gt;50%, combined low IDO-1 Score and high UICC stage showed significantly worse 3-year-PFS and – OS values (p&lt;0.05).
Conclusion: The study identifies PD-L1 and IDO-1 as possible prognostic factors for sinonasal SCC, but less so for sinonasal AC. A TPS Score &gt;50% and combined low IDO-1 score correlate with shortened 3-year-PFS and -OS in sinonasal SCC. Immune checkpoints could therefore represent important target molecules for the prognosis assessment of sinonasal SCC.